Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

idrabiotaparinux

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Covering: up to November 2013. Heparin and heparan sulfate are natural polysaccharides with strong structural variations, which… Expand
Highly Cited
2012
Highly Cited
2012
BACKGROUND Treatment of pulmonary embolism with low-molecular-weight heparin and vitamin K antagonists, such as warfarin, is not… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2011
Highly Cited
2011
Summary.  Background: Idraparinux, a long acting inhibitor of factor (F) Xa, is as effective as standard anticoagulant therapy… Expand
2011
2011
The association between cancer and venous thromboembolism (VTE) has been well documented in the literature. Prevention and… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Highly Cited
2010
Highly Cited
2010
Summary.  Background:  Idraparinux is an inhibitor of activated factor X (FXa) with a long half‐life allowing once‐weekly dosing… Expand
2010
2010
  • J. Harenberg
  • Expert review of clinical pharmacology
  • 2010
  • Corpus ID: 207209495
Idraparinux is a polymethylated synthetic pentasaccharide that binds to antithrombin with high affinity. Idrabiotaparinux is a… Expand
Review
2010
Review
2010
  • J. Weitz
  • Thrombosis research
  • 2010
  • Corpus ID: 31157750
Cancer-associated thrombosis is a major cause of morbidity and mortality. Although anticoagulation remains the mainstay for… Expand
  • table 1
  • table 2
Review
2009
Review
2009
  • J. Harenberg
  • Thrombosis and haemostasis
  • 2009
  • Corpus ID: 10817514
Idraparinux is an analogue of fondaparinux binding with high affinity to antithrombin. It was designed for weekly, rather than… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
2009
2009
Summary.  Background: Idraparinux, a long‐acting synthetic pentasaccharide, is a specific antithrombin‐dependent inhibitor of… Expand
2008
2008
Idrabiotaparinux is a novel synthetic anticoagulant that links idraparinux, a specific, indirect factor Xa inhibitor, to biotin… Expand